Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Carmila SAS (CUX1) Stock Price & Analysis

0 Followers

CUX1 Stock Chart & Stats

€14.78€0.16(1.09%)
At close: 5:30 PM GMT+1
€14€14.5€15Sep 14Oct 7Oct 16Oct 29
Day’s Range
EUR 14.78 - EUR 14.78
52-Week Range
EUR 13.98 - EUR 18.52
Previous Close
EUR 14.62
Volume
N/A
Average Volume (3M)
46
Market Cap
EUR 2.09B
Enterprise Value
EUR 5.00B
Total Cash (Recent Filing)
EUR 85.36M
Total Debt (Recent Filing)
EUR 2.77B
Price to Earnings (P/E)
7.3
Beta
0.56
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
8.87%

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Revenue accelerated to 73.3% growth in 2025 from 4.3% in 2024, indicating stronger recent top-line momentum. For a shopping-center owner, higher revenue can support leasing activity, asset operations, and reinvestment, although durability depends on maintaining this pace.

Profitability

Gross margins have remained about 68%–76% historically, while net margins were 61.9% in 2024 and 32.3% in 2025. This profitability profile gives Carmila meaningful earnings capacity from its retail-property platform and supports resilience when revenue growth moderates.

Cash Generation

Operating cash flow reached €238M and free cash flow €216M in 2025, with FCF equal to about 91% of net income. This close conversion indicates that reported profits are backed by cash, supporting debt service, property investment, and shareholder distributions.

Bears Say

Leverage

Debt was roughly 0.80x equity in 2025, within a 0.74x–0.93x range, making leverage a material exposure for the retail REIT. Higher rates or weaker property performance could reduce financial flexibility and pressure cash available for investment or distributions.

Earnings Volatility

Earnings have not followed a stable trajectory: Carmila recorded a loss in 2020, was near breakeven in 2023, and then posted strong margins in 2024–2025. Such swings make normalized profitability less predictable and weaken confidence that recent earnings can persist through the cycle.

Free Cash Flow Volatility

Free cash flow fell 23.5% in 2025 despite remaining positive, while operating cash flow relative to earnings has been inconsistent historically. The decline and uneven conversion introduce uncertainty around the reliability of internally generated funds for ongoing capital needs and distributions.

Carmila SAS News

CUX1 FAQ

What was Carmila SAS’s price range in the past 12 months?
Carmila SAS lowest stock price was €13.98 and its highest was €18.52 in the past 12 months.
What is Carmila SAS’s market cap?
Carmila SAS’s market cap is €2.09B.
When is Carmila SAS’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Carmila SAS’s earnings last quarter?
Carmila SAS released its earnings results on Jul 29, 2026. The company reported €0.97 earnings per share for the quarter, beating the consensus estimate of €0.95 by €0.02.
Is Carmila SAS overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Carmila SAS pay dividends?
Carmila SAS does not currently pay dividends.
What is Carmila SAS’s EPS estimate?
Carmila SAS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Carmila SAS have?
Carmila SAS has 139,616,610 shares outstanding.
What happened to Carmila SAS’s price movement after its last earnings report?
Carmila SAS reported an EPS of €0.97 in its last earnings report, beating expectations of €0.95. Following the earnings report the stock price went up 0.735%.
Which hedge fund is a major shareholder of Carmila SAS?
Currently, no hedge funds are holding shares in DE:CUX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology